Related Experiment Video

Updated: Aug 8, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Toxicity to tumour cells of diethylaminoreserpine

S Lehnert

    The British Journal of Cancer. Supplement
    |April 1, 1980
    PubMed

    Insights

    Diethylaminoreserpine (DL-152), a phosphodiesterase inhibitor, effectively kills KHT fibrosarcoma cells, particularly hypoxic ones. Tumor cell killing is dose-dependent on tumor size, with rapid repopulation observed post-treatment.

    Area of Science:

    • Oncology
    • Pharmacology
    • Cancer Biology

    Background:

    • Diethylaminoreserpine (DL-152) is a cyclic AMP phosphodiesterase inhibitor.
    • Cancer cells, especially hypoxic ones, exhibit differential drug sensitivity.
    • Understanding drug effects on tumor cell kinetics is crucial for effective cancer therapy.

    Purpose of the Study:

    • To investigate the efficacy of Diethylaminoreserpine (DL-152) in eliminating clonogenic KHT fibrosarcoma cells.
    • To assess the differential toxicity of DL-152 towards hypoxic versus aerated tumor cells.
    • To determine the impact of DL-152 on tumor cell survival, repopulation, and growth dynamics.

    Main Methods:

    • Intraperitoneal administration of DL-152 to tumor-bearing mice.
    • Assessment of clonogenic cell survival at various time points post-injection.
    • Correlation of cell killing with tumor size and evaluation of tumor growth rates.

    Main Results:

    • DL-152 demonstrated toxicity to clonogenic KHT fibrosarcoma cells.
    • DL-152 exhibited greater toxicity to acutely hypoxic cells compared to aerated cells.
    • A progressive decline in surviving clonogenic cells was observed up to 48 hours, followed by rapid repopulation.
    • The extent of cell killing was directly proportional to the initial tumor size.
    • Small tumors showed no significant growth rate change, while larger tumors experienced a temporary growth delay.

    Conclusions:

    • DL-152 is effective in reducing clonogenic tumor cell burden in KHT fibrosarcoma.
    • Hypoxic tumor cells are more susceptible to DL-152 treatment.
    • Tumor size is a critical factor influencing DL-152's therapeutic effect.
    • DL-152 may offer a therapeutic window for targeting specific tumor cell populations.

    More Related Videos

    Viability Assays for Cells in Culture12:03

    Viability Assays for Cells in Culture

    Published on: January 20, 2014

    Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment04:48

    Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment

    Published on: January 7, 2015

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Physical Properties of Amines01:26

    Physical Properties of Amines

    Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
    Drugs Affecting Neurotransmitter Release or Uptake01:21

    Drugs Affecting Neurotransmitter Release or Uptake

    Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
    Drugs Affecting Neurotransmitter Synthesis01:29

    Drugs Affecting Neurotransmitter Synthesis

    Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
    Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

    Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

    Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
    Phenothiazines, such as prochlorperazine...
    Drug Toxicity: Dose-Dependent Reactions01:24

    Drug Toxicity: Dose-Dependent Reactions

    Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...